ArticleMolecular biology reports2026
Trem2 regulates macrophage phenotype via the JAK2/STAT3 signaling pathway to ameliorate ventricular remodeling after acute myocardial infarction.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundPathological ventricular remodeling after acute myocardial infarction (AMI) is a critical pathological basis of heart failure, with macrophages as the core driver of inflammatory imbalance. Trem2-expressing macrophages regulate inflammation resolution and tissue repair, and the JAK2/STAT3 pathway is involved in macrophage phenotype modulation. However, whether Trem2 regulates macrophage polarization and improves ventricular remodeling via this pathway post-AMI remains unclear. This study aimed to explore the regulatory role of the Trem2-JAK2/STAT3 axis in macrophage polarization and ventricular remodeling after AMI.
methodsDynamic Trem2 expression was detected in a mouse AMI model. Myeloid-specific Trem2 knockout mice (Mac-Trem2KO) were generated, and cardiac function, infarct size, cardiomyocyte apoptosis, collagen deposition and survival rate were compared between knockout and control groups. The GSE218002 dataset and myocardial tissues were used to verify the effect of Trem2 deficiency on macrophage phenotypes. sTREM2 supplementation and AG490 inhibition were performed to verify the JAK2/STAT3 pathway-mediated regulatory mechanism.
resultsTrem2 expression was upregulated after AMI and peaked at the repair phase. Compared with controls, Mac-Trem2KO mice showed more severe ventricular remodeling and cardiac dysfunction. Trem2 deficiency suppressed JAK2/STAT3 pathway activation and skewed macrophages toward a pro-inflammatory phenotype. Exogenous sTREM2 restored pathway activity and ameliorated cardiac function, while AG490 recapitulated the cardiac dysfunction induced by Trem2 deficiency.
conclusionTrem2 mediates macrophage phenotypic switching by activating the JAK2/STAT3 pathway in macrophages, thus inhibiting pathological ventricular remodeling. The Trem2-JAK2/STAT3 signaling axis represents a promising therapeutic target for post-AMI myocardial remodeling.
Indexed as
Identifiers
42658285What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.